Queen's University Belfast

The genetic evidence supports a link between migrations and important cultural shifts like the emergence of agriculture or metal tools occurring in parallel.

By Justin Petrone
Almac Diagnostics has moved closer to launching its microarray-based test for stage II colorectal cancer recurrence and plans to debut it in the US sometime next year.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Almac today said that it is teaming up with researchers at Queen's University, Belfast to develop pharmacogenomics tests for a variety of cancers.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.